As part of our commitment to providing cutting-edge wound healing products to physicians and patients, the company researches the latest trends, therapies, and applications in the hospital/wound care markets.
> Muliticenter, Open Trial in Japan of the Novel Completely Autologous Fibrin Sealant CryoSeal FS System: Excellent Performance, Efficacy and Safety Demontrated for Use during Surgical Procedures
> Performance Of Cryoseal® FS In Liver Surgery
> A Multicenter Randomized Clinical Trial Using Fibrin Sealant, Produced by the CryoSeal FS System in Patients Undergoing Liver Resection
> Preparation and Characterization of Autologous Fibrin Glue
> The Autologous Production & Use of Fibrin Glue in Urologic Surgery
> Home-Made Versus Commercial Fibrin Glue in Liver Surgery
> Procoagulant Properties of Fibrin Sealant Generated From a Single Unit of Plasma by a Novel Automated Method (CryoSeal)
> The Use of Autologous Fibrin Glue to Reduce Perioperative Blood Loss in a Total Knee Arthroplasty - Results of a Controlled Study
> Fibrin Glue Prepared from Single Donor Allogenous Plasma
> Use of an Autologous Fibrin Sealant (CryoSeal FS) Reduces Transfusion Requirements
> THERMOGENESIS CORP. MEETS CLINICAL ENDPOINTS OF PHASE III CLINICAL TRIAL OF CRYOSEAL® FIBRIN SEALANT (FS) SYSTEM
> Use of CryoSeal-derived Autologous Fibrin Sealant in Duodenal Hematoma
> Production of an Autologous Thrombin for Use in a Fibrin Sealant
> Quality of Thrombin Produced From the Patient's Own Plasma Using the TPD, a New Thrombin-Processing Device
> Evaluation of Thrombin Produced from a Single Unit of Plasma Using the Thrombin Activation Device
> Evaluation of Platelet Gel Characteristics Using Thrombin Producing Device: A Comparative Study